Literature DB >> 17142991

Cry-consensus peptide, a novel peptide for immunotherapy of Japanese cedar pollinosis, induces Th1-predominant response in Cry j 1-sensitized B10.S mice.

Daisuke Kozutsumi1, Masako Tsunematsu, Taketo Yamaji, Rika Murakami, Minehiko Yokoyama, Kohsuke Kino.   

Abstract

Cry-consensus peptide (CCP) is a newly designed peptide for peptide-based immunotherapy of Japanese cedar pollinosis but its mechanism of efficacy is unknown. We investigated the effect of CCP on Cry j 1-specific Th1/Th2 response in a mice model. Subcutaneous injection of CCP decreased Cry j 1-specific IgE and IgG1 in blood slightly, but the IgG2a level was increased significantly in a dose dependent manner. Splenocytes from these mice were stimulated with Cry j 1 in vitro. This inhibited IL-4, IL-5 and IL-10 secretion significantly, but IFN-gamma secretion was increased. In vitro CCP stimulation of splenocytes from Cry j 1-sensitized mice induced more marked Th1-predominancy of cytokine production than native allergen stimulation. Taken together, these data suggest that one of the mechanisms of CCP is dependent on the modulation of the antigen-specific Th1/Th2 response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142991     DOI: 10.1248/bpb.29.2506

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

Review 1.  T-cell responses induced by allergen-specific immunotherapy.

Authors:  E Maggi
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

2.  Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naïve and Sensitized BALB/c Mice.

Authors:  Neelkamal Chaudhary; Lakshna Mahajan; Taruna Madan; Anil Kumar; Gajendra Pratap Singh Raghava; Seturam Bandacharya Katti; Wahajul Haq; Puranam Usha Sarma
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

3.  A combination of cross correlation and trend analyses reveals that Kawasaki disease is a pollen-induced delayed-type hyper-sensitivity disease.

Authors:  Akira Awaya; Chiaki Nishimura
Journal:  Int J Environ Res Public Health       Date:  2014-03-04       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.